|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization, net | |||||
| Amortization of deferred financing costs | |||||
| Amortization of fair value adjustments of mortgage notes payable assumed | |||||
| Amortization and accretion on deferred loan fees | |||||
| Amortization of premiums and discounts on credit investments | |||||
| Accretion of interest income on CLO subordinated note | |||||
| Capitalized interest income on real estate-related securities and loans held-for-investment | |||||
| Equity-based compensation | |||||
| Straight-line rental income | |||||
| Recovery of uncollectible lease-related receivables | |||||
| Gain on disposition of real estate assets and condominium developments, net | |||||
| Loss on sale of credit investments, net | |||||
| Gain on investment in unconsolidated entities | |||||
| Gain on sale of marketable security | |||||
| Unrealized (gain) loss on equity securities | |||||
| Amortization of fair value adjustment and gain on interest rate swaps | |||||
| Impairment of real estate assets | |||||
| Increase in provision for credit losses | |||||
| Loss on interest rate caps | |||||
| Return on investment in unconsolidated entities | |||||
| Write-off of deferred financing costs | |||||
| Changes in operating assets and liabilities: | |||||
| Rents and tenant receivables, net | |||||
| Prepaid expenses and other assets | |||||
| Accrued interest receivable | |||||
| Accrued expenses and accounts payable | |||||
| Deferred rental income and other liabilities | |||||
| Due to affiliates | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash acquired in connection with mergers | |||||
| Investment in unconsolidated entities | |||||
| Return of investment in unconsolidated entities | |||||
| Investment in real estate-related securities and other | |||||
| Investment in liquid corporate senior loans | |||||
| Investment in corporate senior loans | |||||
| Investment in real estate assets and capital expenditures | |||||
| Net proceeds from deeds-in-lieu of foreclosure | |||||
| Origination and funding of first mortgage loans | |||||
| Origination, modification and exit fees received on loans held-for-investment | |||||
| Principal payments received on loans held-for-investment | |||||
| Principal payments received on real estate-related securities | |||||
| Proceeds from the repayment on the CLO subordinated note | |||||
| Net proceeds from sale of real estate-related securities | |||||
| Net proceeds from disposition of real estate assets and condominium developments | |||||
| Net proceeds from sale of liquid corporate senior loans | |||||
| Redemption of investment in unconsolidated entities | |||||
| Payment of property escrow deposits | |||||
| Refund of property escrow deposits | |||||
| Proceeds from the settlement of insurance claims | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Redemptions of common stock | |||||
| Distributions to stockholders | |||||
| Proceeds from borrowings | |||||
| Repayments of borrowings, and prepayment penalties | |||||
| Termination of interest rate swaps | |||||
| Payment of loan deposits | |||||
| Refund of loan deposits | |||||
| Deferred financing costs paid | |||||
| Contributions from non-controlling interests | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Reconciliation of cash and cash equivalents and restricted cash to the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...